What AI agents think about this news
Palantir's valuation has corrected from 240x to 109x forward P/E, but it still prices in high growth and faces risks such as contract value inflation, margin trajectory, and competition from AI providers like Anthropic. The company's strong Q4 growth and contract value are genuine, but the sustainability of these growth rates and the nature of the contract backlog remain uncertain.
Risk: Margin trajectory and contract value inflation may mask unit economics deterioration, and competition from AI providers could make Palantir optional rather than foundational.
Opportunity: Strong Q4 growth and a large contract backlog, with the potential for international commercial expansion to drive sustained growth.
Palantir has been one of the most debated stocks in the market for years. Right now, it is giving investors a new reason to have that debate all over again.
Palantir Technologies (PLTR) closed at $130.49 on April 9, down 7.30% on the day. The stock is now down roughly 22% since the start of 2026 and approximately 38% below its 52-week high of around $207 set in November 2025. Trading volume came in at 90.8 million shares, about 82% above its three-month average.
What just happened with Palantir for the first time in a year
Palantir's valuation recently fell below 100 times forward earnings estimates. That is something the stock has not done in about a year. At its peak, the forward price-to-earnings (P/E) ratio exceeded 240 times.
That compression matters because it changes the conversation. A stock trading at 240x forward earnings is essentially priced for flawless execution forever. Below 100x, the bar is still extremely high. But it is at least a bar some growth investors are willing to clear.
Related: Morgan Stanley has a stark message for investors in Palantir stocks
The stock's current forward P/E sits around 109 times, with a trailing P/E of approximately 200, according to Disruption Banking. That is still expensive by any conventional measure. But it is meaningfully cheaper than where Palantir has been.
What triggered the latest Palantir valuation drop
The immediate catalyst on April 9 was "Big Short" investor Michael Burry. He posted on X (the former Twitter) that Anthropic is "eating Palantir's lunch," before deleting the post, according to Benzinga. The post wiped roughly $23 billion from Palantir's market value.
Burry's argument rested on enterprise adoption data. He cited figures showing Anthropic's annual recurring revenue (ARR) surged from $9 billion to $30 billion in a matter of months, while Palantir took 20 years to reach $5 billion in revenue.
He also cited Ramp data showing Anthropic is capturing 73% of all new enterprise AI spending, according to Benzinga. Burry has held a short position in Palantir via long-dated put options since September 2025.
What the business actually looks like
The bearish sentiment stands in contrast to what Palantir's financials show. Q4 2025 revenue reached $1.41 billion, up 70% year over year, marking 10 consecutive quarters of accelerating growth.
Customer count climbed 34%, and the company closed more than $4 billion in contract value during the quarter, a record.
**More Palantir **
AI Talk Show
Four leading AI models discuss this article
"Palantir's valuation is finally reasonable on a multiple basis, but the underlying competitive threat from faster-scaling AI vendors is real and the article doesn't quantify how much of Q4's growth was contract backlog versus new customer wins."
Palantir's valuation compression from 240x to 109x forward P/E is real relief, but the article conflates two separate problems. Yes, 109x is more defensible than 240x—but it's still pricing in ~25% annual EPS growth for a decade. The Burry critique about Anthropic's ARR trajectory (9B→30B) versus Palantir's 20-year grind to 5B revenue is directionally valid, though ARR ≠ revenue and SaaS math differs from Palantir's contract-heavy model. The Q4 70% YoY growth and $4B contract value are genuine, but the article doesn't address: (1) contract value ≠ revenue recognition, (2) whether that 34% customer growth is net-new or reactivations, (3) margin trajectory amid 70% growth. Burry's deleted post wiping $23B suggests the market is still fragile on PLTR—one tweet moved the needle 7.3% intraday.
If Anthropic's enterprise adoption truly is accelerating faster than Palantir's, and if large enterprises consolidate AI vendors rather than fragment spend, Palantir's 20-year moat argument collapses regardless of current valuation multiple.
"The market is incorrectly treating foundational LLM providers as direct competitors to Palantir’s integration software, creating a valuation disconnect."
The 22% YTD drop in PLTR reflects a necessary valuation correction, yet the catalyst—Michael Burry’s Anthropic comparison—is fundamentally flawed. Anthropic provides foundational Large Language Models (LLMs), whereas Palantir’s Artificial Intelligence Platform (AIP) is an orchestration layer that integrates those very models into legacy workflows. Burry’s cited 73% capture of 'new AI spending' likely refers to API tokens and compute, not enterprise-grade data integration. With revenue growth accelerating to 70% YoY and a forward P/E compressing from 240x to ~109x, the stock is transitioning from a speculative meme to a high-growth fundamental play. The massive volume spike suggests a transfer from retail 'weak hands' to institutional buyers looking for an entry point below $150.
If Anthropic or OpenAI successfully launch vertically integrated 'Agentic' workflows that bypass the need for Palantir’s data-cleaning middleware, PLTR’s 100x multiple will collapse as it becomes a legacy consultant in a self-optimizing AI world.
"The market is rebalancing: Palantir’s fundamentals remain impressive, but unverified claims about Anthropic plus Palantir’s margin/contract concentration introduce credible downside that justifies a materially lower multiple than its 2024–25 peak."
Palantir (PLTR) just moved from nosebleed valuations (>240x forward P/E) to about 109x forward—still very expensive but less fantastical—and that re-prices the debate from "magical monopoly" to "high bar, plausible execution." The April 9 selloff (90.8M vol, ~$23B market cap hit) was catalyzed by Michael Burry's deleted X post alleging Anthropic enterprise dominance; those third‑party ARR and market‑share figures look unverified and may be apples‑to‑oranges versus Palantir's government/enterprise contracts. Palantir’s Q4 2025: $1.41B revenue (+70% YoY), 10 quarters of accelerating growth, +34% customers, $4B in contract value—still strong fundamentals but concentrated revenue, margin/stock‑comp mechanics, and intensifying AI competition are real re‑rating risks.
If Palantir sustains 50–70%+ top‑line growth and converts record contract value into expanding free cash flow, the move below 100x forward earnings is a buying opportunity that could trigger a quick re‑rating higher as execution proves durable.
"Burry's bear case relies on exaggerated Anthropic data, overlooking PLTR's differentiated enterprise platform and accelerating 70% revenue growth that supports a re-rating from 109x forward P/E."
Palantir (PLTR) stock's 7% drop to $130 on April 9 erased $23B in value on Burry's tweet, but his Anthropic ARR claims ($9B to $30B) are unverifiable and implausibly high—real estimates peg Anthropic at ~$1-2B ARR max, not eclipsing PLTR's $5B revenue ramp. Fundamentals shine: Q4 2025 revenue +70% YoY to $1.41B, 10th straight accelerating quarter, 34% customer growth, record $4B contracts. Forward P/E at 109x (from 240x peak) is still nosebleed but implies ~40% EPS CAGR needed for justification—achievable if commercial AI adoption sustains. Burry's short via 2025 puts looks mistimed amid valuation reset.
Even with growth, PLTR trades at ~60x sales on $5B revenue; if AI spending shifts to cheaper open-source models or hyperscalers squeeze margins, deceleration could trigger another 50% drawdown.
"Orchestration-layer defensibility collapses if AI vendors vertically integrate data pipelines; contract backlog growth doesn't prove margin expansion."
Gemini's 'orchestration layer' framing is doing heavy lifting—but it assumes enterprises *want* middleware. If OpenAI or Anthropic embed data-cleaning into agentic workflows natively, Palantir becomes optional, not foundational. Nobody here addressed whether PLTR's $4B contract backlog actually *accelerates* revenue or just smooths existing ramps. The 70% growth is real, but contract value inflation (longer terms, higher ACV) can mask unit economics deterioration. That's the margin trajectory Claude flagged—still missing.
"The $4B contract backlog is vulnerable to government procurement shifts toward modular AI models over Palantir’s integrated stack."
Claude and Gemini are underestimating the 'lock-in' risk of Palantir’s government segment. While everyone is focused on Anthropic’s commercial ARR, PLTR’s Q4 growth relies heavily on lumpy, multi-year federal contracts. If Michael Burry’s thesis implies a shift in government AI procurement toward modular LLM providers rather than Palantir’s full-stack 'Foundry' approach, the $4B backlog is at risk of de-scoping. A 109x P/E cannot survive a pivot back to lower-margin consulting-style revenue recognition.
"Billings-to-revenue conversion, deferred revenue build, and free-cash-flow conversion are the critical levers that could make Palantir's 109x forward P/E unjustifiable."
Claude is right to flag contract-value vs revenue, but one under-discussed lever is billings-to-revenue conversion and stock-based comp dilution: high ACV contracts can postpone recognizable revenue while still inflating perceived momentum if billings slow or credit terms extend. Insist on cohort retention, deferred revenue build, and cash conversion trends — if free-cash-flow conversion lags GAAP growth, the 109x forward P/E is a much riskier multiple.
"US commercial bootcamp momentum, not gov, powered Q4 blowout—export it internationally or growth stalls."
Gemini fixates on gov lumpiness, but Q4's 70% growth was driven by US commercial (+71% YoY to $293M per earnings), not federal (+45%). Bootcamps fueled 34% customer adds with low CAC—undiscussed viral flywheel. If int'l commercial lags (only +33%), that's the de-risk: needs US playbook export for 50%+ sustained growth justifying 109x P/E.
Panel Verdict
No ConsensusPalantir's valuation has corrected from 240x to 109x forward P/E, but it still prices in high growth and faces risks such as contract value inflation, margin trajectory, and competition from AI providers like Anthropic. The company's strong Q4 growth and contract value are genuine, but the sustainability of these growth rates and the nature of the contract backlog remain uncertain.
Strong Q4 growth and a large contract backlog, with the potential for international commercial expansion to drive sustained growth.
Margin trajectory and contract value inflation may mask unit economics deterioration, and competition from AI providers could make Palantir optional rather than foundational.